March 23, 2018 / 7:27 AM / a month ago

BRIEF-Epigenomics FY Net Loss Narrows To EUR 10.2 Million

March 23 (Reuters) - EPIGENOMICS AG:

* IN 2017, EPIGENOMICS’ TOTAL REVENUE DECREASED TO EUR 1.9 MILLION (2016: EUR 4.2 MILLION)

* FY RESEARCH AND DEVELOPMENT COSTS DECREASED TO EUR 4.3 MILLION (2016: EUR 5.1 MILLION)

* FY OPERATING LOSS (EBIT) IN 2017 DECREASED TO EUR -10.3 MILLION (2016: EUR -12.3 MILLION)

* FY NET LOSS FOR YEAR DECREASED TO EUR 10.2 MILLION (2016: EUR 11.2 MILLION

* SEES FY 2018 REVENUE TO INCREASE BUT WILL REMAIN ON LOW LEVELS, RANGING BETWEEN EUR 2.0 MILLION AND EUR 4.0 MILLION

* ANTICIPATES EBITDA BEFORE SHARE-BASED PAYMENT EXPENSES WILL BE IN A RANGE EUR -11.5 MILLION AND EUR -14.0 MILLION IN 2018

* EXPECTS 2018 CASH CONSUMPTION IN LINE WITH OUR EBITDA BEFORE SHARE-BASED PAYMENT EXPENSES GUIDANCE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below